Target intelligence / Profile preview

Beta-alanine betaine N-methyltransferase (BAMT)

Target
BAMT
Molecular classification
Enzyme, Methyltransferase, S-adenosyl-L-methionine-dependent methyltransferase
01

Overview

Beta-alanine betaine N-methyltransferase (BAMT) is a trifunctional enzyme primarily identified in halophytic plants, such as those in the Plumbaginaceae family (e.g., Limonium latifolium) [9, 11]. It catalyzes the sequential three-step N-methylation of beta-alanine to form N-methyl-beta-alanine, N,N-dimethyl-beta-alanine, and finally N,N,N-trimethyl-beta-alanine, also known as beta-alanine betaine, utilizing S-adenosyl-L-methionine as the methyl donor [9, 11]. Beta-alanine betaine serves as a critical osmoprotectant, enabling plants to maintain cellular osmotic balance and protect metabolic machinery under environmental stressors such as salinity, drought, and hypoxia [11]. This enzyme is not found in the human genome, where beta-alanine metabolism is instead focused on its roles as a neurotransmitter or as a precursor for carnosine and coenzyme A synthesis [10, 12, 14]. While BAMT is not a therapeutic target for human diseases, it is a significant target in agricultural biotechnology for the metabolic engineering of stress-tolerant crop varieties [11]. Currently, there are no pharmaceutical drugs or clinical mechanisms of action associated with this enzyme.

Other names
Beta-alanine N-methyltransferaseTrifunctional beta-alanine N-methyltransferaseBBNMTS-adenosyl-L-methionine:beta-alanine N-methyltransferase
02

Biological functions

OsmoprotectionBeta-alanine metabolismMethylationResponse to salt stressResponse to hypoxia

Beyond the preview

Go deeper on Beta-alanine betaine N-methyltransferase (BAMT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-alanine betaine N-methyltransferase (BAMT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call